Back to User profile » Dr Sabrina Bimonte
Papers published by Dr Sabrina Bimonte:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection
Bimonte S, Forte CA, Cuomo M, Esposito G, Cascella M, Cuomo A
Drug Design, Development and Therapy 2021, 15:4447-4454
Published Date: 28 October 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
COVID-Pain: Acute and Late-Onset Painful Clinical Manifestations in COVID-19 – Molecular Mechanisms and Research Perspectives
Cascella M, Del Gaudio A, Vittori A, Bimonte S, Del Prete P, Forte CA, Cuomo A, De Blasio E
Journal of Pain Research 2021, 14:2403-2412
Published Date: 10 August 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Role of Anti-Nerve Growth Factor Monoclonal Antibodies in the Control of Chronic Cancer and Non-Cancer Pain
Bimonte S, Cascella M, Forte CA, Esposito G, Cuomo A
Journal of Pain Research 2021, 14:1959-1967
Published Date: 28 June 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Delayed Emergence from Anesthesia: What We Know and How We Act
Cascella M, Bimonte S, Di Napoli R
Local and Regional Anesthesia 2020, 13:195-206
Published Date: 5 November 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge
Bimonte S, Cascella M
Drug Design, Development and Therapy 2020, 14:4245-4250
Published Date: 12 October 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanisms
Giudice A, Barbieri A, Bimonte S, Cascella M, Cuomo A, Crispo A, D'Arena G, Galdiero M, Della Pepa ME, Botti G, Caraglia M, Capunzo M, Arra C, Montella M
OncoTargets and Therapy 2019, 12:4937-4953
Published Date: 24 June 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Multimodal approaches and tailored therapies for pain management: the trolley analgesic model
Cuomo A, Bimonte S, Forte CA, Botti G, Cascella M
Journal of Pain Research 2019, 12:711-714
Published Date: 19 February 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives
Bimonte S, Albino V, Piccirillo M, Nasto A, Molino C, Palaia R, Cascella M
Drug Design, Development and Therapy 2019, 13:611-621
Published Date: 12 February 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Multiple effectiveness aspects of tapentadol for moderate–severe cancer-pain treatment: an observational prospective study
Cascella M, Forte CA, Bimonte S, Esposito G, Romano C, Costanzo R, Morabito A, Cuomo A
Journal of Pain Research 2019, 12:117-125
Published Date: 24 December 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies
Fiore M, Cascella M, Bimonte S, Maraolo AE, Gentile I, Schiavone V, Pace MC
Infection and Drug Resistance 2018, 11:177-186
Published Date: 26 January 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells
Bimonte S, Barbieri A, Cascella M, Rea D, Palma G, Del Vecchio V, Forte CA, Del Prato F, Arra C, Cuomo A
OncoTargets and Therapy 2018, 11:185-191
Published Date: 3 January 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives
Fiore M, Maraolo AE, Leone S, Gentile I, Cuomo A, Schiavone V, Bimonte S, Pace MC, Cascella M
Therapeutics and Clinical Risk Management 2017, 13:1409-1414
Published Date: 16 October 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives
Bimonte S, Cascella M, Schiavone V, Mehrabi-Kermani F, Cuomo A
Drug Design, Development and Therapy 2017, 11:2737-2742
Published Date: 13 September 2017